Jubilant Ingrevia buys 40% of Zettaone for ₹189.2 crore in electronics push
What's the deal? Jubilant IngreviaDealroom has a profile for this one. Try Dealroom → has signed a binding agreement to acquire a 40% strategic equity stake in Zettaone Technologies India for approximately ₹189.2 crore in cash. Once complete, Zettaone will become an associate company of the specialty chemicals and CDMO player.
What each side brings: Zettaone is a privately held deep-tech firm specialising in electronics design and manufacturing, from R&D to production, with strength in high-speed and high-power PCB work. Jubilant Ingrevia is a global specialty chemicals and contract development and manufacturing organisation with over 45 years in the industry.
Why now? The investment is a step in Jubilant Ingrevia's "Pinnacle" growth strategy, giving it a platform to expand into Electronics Development and Manufacturing Services (EDMS). It aims to offer an integrated value proposition across the electronics and semiconductor value chain.
The terms: The deal will close in two tranches — the first by November 2026 and the second by September 2027. Zettaone reported turnover of ₹98.1 crore for FY25-26, up from ₹79.1 crore the prior year and ₹51.1 crore in FY23-24.
What's the endgame? Jubilant Ingrevia expects Zettaone's expertise to complement its existing CDMO capabilities. Zettaone serves aerospace, defence, semiconductor, automotive, medical, and industrial customers.
The signal: The move reflects a specialty chemicals group broadening beyond its core into electronics and semiconductors, sectors where India is courting domestic manufacturing capacity.
Read more: Investywise
Image credit: Generated with Gemini
